Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- 8 August 2008
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (18) , 5471-5489
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical developmentDrug Discovery Today, 2007
- Preferential inhibition of human phosphodiesterase 4 by ibudilastLife Sciences, 2006
- 7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as Novel Inhibitors of Human Eosinophil PhosphodiesteraseJournal of Medicinal Chemistry, 1998
- Selective Phosphodiesterase Inhibitors in the Therapy of AsthmaClinical Immunotherapeutics, 1995
- New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-onesJournal of Medicinal Chemistry, 1992
- New antiinflammatory agents. 2. 5-Phenyl-3H-imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones: a new class of nonsteroidal antiinflammatory agents with potent activity like glucocorticoidsJournal of Medicinal Chemistry, 1992
- Characterization of the memory gene dunce of Drosophila melanogasterJournal of Molecular Biology, 1991
- Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogsJournal of Medicinal Chemistry, 1989
- Effects of enprofylline and theophylline may show the role of adenosineLife Sciences, 1986
- TVX 2706 — a new phosphodiesterase inhibitor with antiinflammatory action Biochemical characterizationInflammation Research, 1984